HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Sayantani B Sindher Selected Research
Sayantani B Sindher Research Topics
Disease
15
Hypersensitivity (Allergy)
03/2024 - 07/2018
13
Food Hypersensitivity (Food Allergy)
03/2024 - 10/2018
10
Peanut Hypersensitivity (Peanut Allergy)
03/2024 - 09/2018
4
COVID-19
11/2023 - 01/2022
2
Eosinophilic Esophagitis
01/2023 - 01/2021
2
Anaphylaxis (Anaphylactic Shock)
01/2022 - 01/2021
2
Asthma (Bronchial Asthma)
01/2022 - 07/2018
2
Atopic Dermatitis (Atopic Eczema)
01/2022 - 01/2020
1
Milk Hypersensitivity (Milk Allergy)
02/2024
1
Injection Site Reaction
01/2024
1
Lung Diseases (Lung Disease)
01/2022
1
Infections
01/2022
1
Inflammation (Inflammations)
01/2020
1
Opportunistic Infections (Opportunistic Infection)
02/2015
1
Immune Reconstitution Inflammatory Syndrome
02/2015
1
Chronic Urticaria
11/2012
Drug/Important Bio-Agent (IBA)
8
Allergens
IBA
02/2024 - 01/2020
6
Immunoglobulin E (IgE)
IBA
02/2024 - 07/2018
4
Antigens
IBA
11/2023 - 01/2022
4
Biomarkers (Surrogate Marker)
IBA
11/2023 - 10/2018
4
Vaccines
IBA
11/2023 - 01/2021
3
Omalizumab (Xolair)
FDA Link
01/2024 - 07/2018
3
mRNA Vaccines
IBA
01/2023 - 01/2021
2
dupilumab
IBA
03/2024 - 01/2023
2
Antibodies
IBA
03/2024 - 01/2022
2
Proteins (Proteins, Gene)
FDA Link
05/2023 - 01/2022
2
COVID-19 Vaccines
IBA
01/2023 - 01/2021
2
Emollients
IBA
10/2022 - 01/2020
2
Epinephrine (Adrenaline)
FDA Link
Generic
01/2022 - 01/2020
2
Immunoglobulin G (IgG)
IBA
01/2022 - 01/2021
2
Messenger RNA (mRNA)
IBA
01/2022 - 01/2021
1
tezepelumab
IBA
03/2024
1
ligelizumab
IBA
03/2024
1
anti-IgE antibodies
IBA
01/2024
1
Avidin
IBA
11/2023
1
Excipients (Suspending Agents)
IBA
01/2023
1
Vaccine Excipients
IBA
01/2023
1
Steroids
IBA
10/2022
1
BIBP COVID-19 vaccine
IBA
01/2022
1
remdesivir
IBA
01/2022
1
BNT162 Vaccine
IBA
01/2022
1
Legumins
IBA
01/2021
1
Histamine Antagonists (Antihistamines)
IBA
01/2020
1
DNA (Deoxyribonucleic Acid)
IBA
10/2018
1
Vitamin D
FDA Link
Generic
11/2012
Therapy/Procedure
14
Immunotherapy
03/2024 - 09/2018
3
Therapeutics
01/2022 - 07/2018
2
Biological Therapy
11/2023 - 02/2015
1
Secondary Prevention
01/2020
1
Highly Active Antiretroviral Therapy (HAART)
02/2015